In vivo study and models for COVID-19 drug development
Service description
In vivo tests and studies that can be used for the development of a therapeutic molecule for the treatment of COVID-19.
SARS-CoV-2 specific models have been developed and are made available for the development of antiviral drugs.
In vivo models:
Efficacity of compounds in a SARS-CoV-2 model (study of survival and quantification of viral load)
K18-hACE2mouse model
Non human primate: cynomolgus macaque
Golden Syrian hamster
Pulmonary fibrosis model (COVID-19 patients may progress to Acute Respiratory Distress Syndrome, of which a subset of survivors will develop lung fibrosis).
This service is designed for Biotech companies developing SARS-CoV-2 new drugs.
Materials to provide
Details about the request.
Compounds or library to test.
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
Typical deliverables
Antiviral activity testing of any type of drug (biological or small molecule).
Study following the specifications validated with the Expert.
Get started with your COVID-19 in vivo assays request
Please answer the fields below to be contacted by our team of scientists
